Ok... So got a question on nmus and the drop... Basically it boils down to people not understanding that the 8k was a finance that provides working capital for the 5 pre-clinical trials and simultaneously locks up management for long term. Roth Capital works a lot with a bunch of Nasdaq biotech companies... They're legit, my feeling is it bounces as long as it closes over .66... In which case I think it heads back over a dollar to 1.3 which was support that it bounced off twice yesterday. For what it's worth.
News 
Market Data 
Discover 
